相关实验视频

Updated: Jul 25, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

[扩展阶段小细胞肺癌的免疫疗法:研究进展和未来前景]

Yuling Zhong^1,2, Jingyi Wang², Lin Wu²

¹Graduate Collaborative Training Base of Hunan Cancer Hospital, University of South China, Hengyang Medical School, Hengyang 421001, China.

Zhongguo fei ai za zhi = Chinese journal of lung cancer

|January 12, 2025

概括

免疫疗法与化疗相结合是扩散阶段小细胞肺癌 (ES-SCLC) 的标准治疗方法. 本综述涵盖了ES-SCLC免疫疗法的近期进展,包括免疫检查点抑制剂 (ICI),以及未来的方向.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
肺部病理学肺部病理学

背景情况:

免疫疗法与化疗相结合是扩散阶段小细胞肺癌 (ES-SCLC) 的标准第一线治疗方法.
免疫检查点抑制剂 (ICI) 是肺癌研究的一个重要焦点.
仍然存在挑战,包括生物标志物发现,新的治疗策略和管理特殊群体.

研究的目的:

审查目前针对扩散阶段小细胞肺癌的免疫疗法的研究进展.
讨论这个领域的挑战和未来方向.
突出免疫检查点抑制剂 (ICI) 在ES-SCLC治疗中的作用.

主要方法:

关于ES-SCLC免疫疗法的最新研究的文献综述.
分析研究趋势和临床试验结果.
讨论新兴生物标志物和治疗模型.

主要成果:

结合免疫疗法和化疗已被确立为ES-SCLC的第一线治疗.
ICI看起来很有前途,但在生物标志物识别和应用方面面临挑战.
目前正在进行的研究旨在克服耐药性并改善患者的治疗结果.

结论:

在ES-SCLC免疫疗法方面取得了重大进展.
需要进一步的研究来优化治疗策略和解决现有挑战.
未来的ES-SCLC治疗可能涉及个性化免疫治疗方法.

关键词:

生物标志物生物标志物免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.肺部的新生病是肺部的新生病.

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...